Business · 09/10/2026Updated: 10/15/2026 · 1 min read
The Food and Drug Administration (FDA, Agency, or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Summary
The FDA is submitting a proposed collection of information for review and clearance to support Expanded Access to Investigational Drugs for Treatment Use.
Original source language: Federal Register — Health and Human ServicesOpen original release →